Cargando…
P53: A Guardian of Immunity Becomes Its Saboteur through Mutation
Awareness of the importance of immunity in controlling cancer development triggered research into the impact of its key oncogenic drivers on the immune response, as well as their value as targets for immunotherapy. At the heart of tumour suppression is p53, which was discovered in the context of vir...
Autores principales: | Agupitan, Arjelle Decasa, Neeson, Paul, Williams, Scott, Howitt, Jason, Haupt, Sue, Haupt, Ygal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278985/ https://www.ncbi.nlm.nih.gov/pubmed/32414156 http://dx.doi.org/10.3390/ijms21103452 |
Ejemplares similares
-
P53 at the start of the 21st century: lessons from elephants
por: Haupt, Sue, et al.
Publicado: (2017) -
Cancer and Tumour Suppressor p53 Encounters at the Juncture of Sex Disparity
por: Haupt, Sue, et al.
Publicado: (2021) -
TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival
por: Freudenstein, Donald, et al.
Publicado: (2020) -
Mutant p53 Drives Cancer by Subverting Multiple Tumor Suppression Pathways
por: Haupt, Sue, et al.
Publicado: (2016) -
p53 Calls upon CIA (Calcium Induced Apoptosis) to Counter Stress
por: Haupt, Sue, et al.
Publicado: (2015)